Showing results (81-90 of 124) with videos related to
Sort By:
Pageof 13
European Heart Journal. Cardiovascular Pharmacotherapy|February 1, 2018
Antithrombotic therapy use and clinical outcomes following thrombo-embolic events in patients with atrial fibrillation: insights from ARISTOTLEShinya Goto, Peter Merrill, Lars Wallentin, et al.Heart (British Cardiac Society)|September 14, 2018
Effect of apixaban compared with warfarin on coagulation markers in atrial fibrillationChristina Christersson, Lars Wallentin, Ulrika Andersson, et al.Journal of Thrombosis and Thrombolysis|April 12, 2019
International normalized ratio control and subsequent clinical outcomes in patients with atrial fibrillation using warfarinPatricia O Guimarães, Renato D Lopes, John H Alexander, et al.Journal of Thrombosis and Thrombolysis|February 22, 2019
Interacting medication use and the treatment effects of apixaban versus warfarin: results from the ARISTOTLE TrialJeffrey B Washam, Stefan H Hohnloser, Renato D Lopes, et al.International Journal of Radiation Oncology, Biology, Physics|March 9, 2023
A Randomized Feasibility Trial of Stereotactic Prostate Radiation Therapy With or Without Elective Nodal Irradiation in High-Risk Localized Prostate Cancer (SPORT Trial)Orla A Houlihan, Kelly Redmond, Ciaran Fairmichael, et al.Cardiovascular Drugs and Therapy|May 19, 2017
Effect of Apixaban on All-Cause Death in Patients with Atrial Fibrillation: a Meta-Analysis Based on Imputed Placebo EffectPatrícia O Guimarães, Renato D Lopes, Daniel M Wojdyla, et al.American Heart Journal|March 8, 2017
Anemia is associated with bleeding and mortality, but not stroke, in patients with atrial fibrillation: Insights from the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) trialB Daan Westenbrink, Marco Alings, Christopher B Granger, et al.Circulation|February 19, 2019
Efficacy and Safety of Apixaban Versus Warfarin in Patients With Atrial Fibrillation and Extremes in Body WeightStefan H Hohnloser, Marat Fudim, John H Alexander, et al.European Heart Journal|September 16, 2015
Clinical outcomes in patients with atrial fibrillation according to sex during anticoagulation with apixaban or warfarin: a secondary analysis of a randomized controlled trialDragos Vinereanu, Susanna R Stevens, John H Alexander, et al.Journal of the American College of Cardiology|September 24, 2013
High-sensitivity troponin T and risk stratification in patients with atrial fibrillation during treatment with apixaban or warfarinZiad Hijazi, Lars Wallentin, Agneta Siegbahn, et al.Pageof 13